Search

Illumina Inc

Suletud

SektorTervishoid

243.11 7.34

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

222.31

Max

235.4

Põhinäitajad

By Trading Economics

Sissetulek

-268M

-134M

Müük

68M

1.2B

P/E

Sektori keskmine

38.773

56.432

Aktsiakasum

1.31

Kasumimarginaal

-11.562

Töötajad

8,600

EBITDA

80M

330M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

-9.63% downside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

29. okt 2026

Turustatistika

By TradingEconomics

Turukapital

2.8B

31B

Eelmine avamishind

235.77

Eelmine sulgemishind

243.11

Uudiste sentiment

By Acuity

19%

81%

23 / 339 Pingereas Healthcare

Illumina Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

16. sept 2026, 23:01 UTC

Illumina Inc. is up in after-market trading, following five consecutive sessions of gains and trading significantly above its 20-day moving average.

15. sept 2026, 23:01 UTC

Illumina Inc's shares are trading higher in after-market hours, benefiting from a broader market rally despite mixed macroeconomic signals.

14. sept 2026, 20:08 UTC

Illumina Inc shares are higher today, though no specific news explains the move. Broader market concerns include rising crude oil prices and inflation.

11. sept 2026, 20:01 UTC

Illumina Inc's shares are higher Friday, continuing an upward trend since Thursday's close. No specific news was identified to explain the movement.

9. sept 2026, 20:07 UTC

Illumina Inc shares are lower today, continuing a decline since Tuesday's close. The stock remains below its 20-day moving average.

8. sept 2026, 23:51 UTC

Illumina Inc shares are higher in after-market trading, showing notable activity and positioning above the 20-day moving average amid a lack of specific news.

5. sept 2026, 00:05 UTC

News

Illumina Inc will join the S&P 500 on September 21, 2026. Shares are advancing in after-market hours following the announcement.

4. sept 2026, 23:02 UTC

News

Illumina Inc will join the S&P 500 index effective September 21, 2026, following an announcement by Dow Jones Indices. Shares are trading higher after the news.

3. sept 2026, 20:07 UTC

News

Illumina shares are higher as analysts raise price targets, with Argus at $235 and Baird at $225, reflecting increased confidence in the company.

2. sept 2026, 22:56 UTC

Illumina Inc's shares are higher in after-market hours following Wednesday's close, maintaining a position above its 20-day moving average. No specific news was identified.

1. sept 2026, 20:09 UTC

Illumina Inc's shares are lower today, continuing a downward trend observed since Monday. The stock has reached a session low, marking a third consecutive decline.

31. aug 2026, 23:36 UTC

Illumina Inc. shares declined in after-market trading, following hawkish comments from Federal Reserve Chair Kevin Warsh that affected market sentiment.

28. aug 2026, 23:16 UTC

Illumina Inc's shares are higher in after-market trading, reflecting positive momentum since Friday's close and routine trading activity within a narrow range.

27. aug 2026, 20:07 UTC

Illumina Inc shares are higher during Thursday's session, supported by a decline in initial jobless claims, though no specific company news was identified.

26. aug 2026, 20:07 UTC

News

Illumina Inc shares are lower today amid a broader downturn in the Life Sciences Tools & Services sub-sector. Analysts estimate fair value at $172.53.

25. aug 2026, 20:07 UTC

News

Illumina Inc shares are advancing as investor sentiment improves ahead of a meeting with Piper Sandler scheduled for August 27.

24. aug 2026, 20:02 UTC

Social Media
News

Illumina Inc reported second-quarter earnings of $1.31 per share, with revenue of $1.16 billion, surpassing estimates. Shares are advancing during Monday's session.

21. aug 2026, 19:16 UTC

Illumina Inc shares are higher today, recovering from earlier losses and remaining above the 20-day moving average for the third consecutive session.

20. aug 2026, 20:02 UTC

Illumina Inc's shares are higher today, building on gains since Wednesday. The stock is trading near the upper end of its one-month range.

19. aug 2026, 20:02 UTC

Correlated Moves

Illumina Inc. shares are higher, buoyed by strong momentum in the genomics sector and a notable rise in the ARK Genomic Revolution ETF.

17. aug 2026, 19:54 UTC

News

Illumina Inc's stock is higher, supported by a Yahoo Finance article discussing its price target of $198.89 and concerns over organic sales performance.

13. aug 2026, 20:06 UTC

Illumina Inc's shares are lower amid declines in the Life Sciences Tools & Services sector, with no specific company news identified for the movement.

12. aug 2026, 22:02 UTC

Illumina Inc shares are lower in after-market hours with no specific news identified. Broader market conditions reflect mixed performance amid inflation data.

11. aug 2026, 19:16 UTC

Illumina Inc. shares are trading higher, recovering from an early dip during Tuesday's session. No specific news or developments were identified.

10. aug 2026, 23:16 UTC

Correlated Moves

Illumina Inc shares fell in after-hours trading, tracking a broader decline in the Russell 2000 Index amid rising U.S. Treasury yields and inflation concerns.

7. aug 2026, 19:46 UTC

News

Illumina Inc shares are lower after Director Keith A. Meister sold 283,269 shares, raising investor concerns about the company's valuation.

6. aug 2026, 23:06 UTC

Illumina Inc shares are lower in after-market trading following Thursday's close, despite an initial uptick. No specific news was identified to explain the decline.

5. aug 2026, 19:52 UTC

Correlated Moves

Illumina shares are lower following disappointing first-quarter results and broader market declines. ADP's report on weak job growth has added to cautious sentiment.

4. aug 2026, 19:31 UTC

Correlated Moves

Illumina Inc's shares are higher today, reflecting a broader market trend as the Russell 2000 Index also advances. The stock is near its one-month range high.

3. aug 2026, 20:03 UTC

News

Illumina shares are lower today as Citigroup maintains a Sell rating and raises its price target to $113 amid mixed analyst sentiment.

Võrdlus sarnastega

Hinnamuutus

Illumina Inc Prognoos

Hinnasiht

By TipRanks

-9.63% langus

12 kuu keskmine prognoos

Keskmine 200.875 USD  -9.63%

Kõrge 260 USD

Madal 113 USD

Põhineb 17 Wall Streeti analüütiku instrumendi Illumina Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

17 ratings

9

Osta

5

Hoia

3

Müü

Sentiment

By Acuity

23 / 339 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Illumina Inc

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.
help-icon Live chat